Adam R Craig Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam R Craig.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam R Craig. Adam R Craig is President and CEO in CTI BIOPHARMA CORP ($CTIC) and See Remarks in CTI BIOPHARMA CORP ($CTIC) and EVP, Development & CMO in SUNESIS PHARMACEUTICALS INC ($SNSS) and VP and Chief Medical Officer in CytRx Oncology Corp ($NA).
Latest Insider Trading Transactions of Adam R Craig
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTIC, NA, SNSS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 3.30 | 800,000 | 2,640,000 | 800,000 | |
| Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Grant | A | 0.98 | 5,000 | 4,900 | 5,000 | 0 to 5 K |
| Mar 13 2020 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 1.00 | 2,320,000 | 2,320,000 | 2,320,000 | |
| May 20 2019 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 0.84 | 1,300,000 | 1,093,430 | 1,300,000 | |
| Sep 20 2018 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 1.88 | 600,000 | 1,128,000 | 600,000 | |
| May 17 2018 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 4.14 | 475,000 | 1,966,500 | 475,000 | |
| Oct 03 2017 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 3.19 | 450,000 | 1,435,500 | 450,000 | |
| Mar 21 2017 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | See Remarks | Option Exercise | A | 4.24 | 1,200,000 | 5,088,000 | 1,200,000 | |
| Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Payment of Exercise | F | 2.22 | 8,302 | 18,430 | 23,452 | 31.8 K to 23.5 K (-26.14 %) |
| Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Grant | A | 0.00 | 19,031 | 0 | 31,754 | 12.7 K to 31.8 K (+149.58 %) |
| Jul 23 2007 | NA | CytRx Oncology Cor ... | Craig Adam R | VP and Chief Medica ... | Option Exercise | A | 5.00 | 37,500 | 187,500 | 37,500 | |
| Jul 23 2007 | NA | CytRx Oncology Cor ... | Craig Adam R | VP and Chief Medica ... | Option Exercise | A | 4.00 | 37,500 | 150,000 | 37,500 | |
| Aug 10 2006 | NA | CytRx Oncology Cor ... | Craig Adam R | VP and Chief Medica ... | Option Exercise | A | 3.96 | 70,000 | 277,200 | 70,000 | |
| Jun 30 2006 | NA | CytRx Oncology Cor ... | Craig Adam R | VP and Chief Medica ... | Option Exercise | C | 3.96 | 17,120 | 67,795 | 17,120 |
Page: 1